The US FDA has proposed to prohibit menthol as a characterizing flavor in cigarettes and prohibit all characterizing flavors (other than tobacco) in cigars.
These actions expand on existing rules established in 2009 that prohibited all cigarette flavors other than tobacco and menthol. They aim to reduce youth experimentation and addiction with combustible tobacco products and increasing the number of smokers that quit. The measures would reduce disease and death from combusted tobacco product use, which is the leading cause of preventable death in the US.
The agency said If these proposed rules are finalized and implemented, FDA enforcement will only address manufacturers, distributors, wholesalers, importers and retailers who manufacture, distribute, or sell such products within the US. The FDA emphasized that the proposed regulations do not include a prohibition on individual consumer possession or use, nor can the agency enforce the proposed rules against individual consumers for possession or use of menthol cigarettes or flavored cigars.
The public will be able to provide comment on these proposed rules beginning May 4, 2022 through July 5, 2022. The agency also will convene public listening sessions on June 13 and June 15 to expand direct engagement with the public, including affected communities.
Menthol Cigarette Ban
According to the FDA, menthol increases appeal and makes menthol cigarettes easier to use, particularly for youth and young adults. Menthol also interacts with nicotine in the brain to enhance nicotine’s addictive effects. The combination of menthol’s flavor, sensory effects and interaction with nicotine in the brain increases the likelihood that youth who start using menthol cigarettes will progress to regular use. Menthol also makes it more difficult for people to quit smoking.
In 2019, there were more than 18.5 million current menthol cigarette smokers ages 12 and older in the US, with particularly high rates of use by youth, young adults, and African American and other racial and ethnic groups.
Published modeling studies have estimated a 15 percent reduction in smoking within 40 years if menthol cigarettes were no longer available in the United States. These studies also estimate that 324,000 to 654,000 smoking attributable deaths overall (92,000 to 238,000 among African Americans) would be avoided over the course of 40 years.
When finalized, the proposed menthol product standard will:
- reduce the appeal of cigarettes, particularly to youth and young adults, decreasing the likelihood that nonusers who would otherwise experiment with menthol cigarettes would progress to regular smoking; and
- improve the health and reduce the mortality risk of current menthol cigarette smokers by decreasing cigarette consumption and increasing the likelihood of cessation.
Flavored Cigar Product Standard Would Reduce Youth Risk
Characterizing flavors in cigars, such as strawberry, grape, cocoa and fruit punch, increase appeal and make cigars easier to use, particularly among youth and young adults. More than a half million youth in the U.S. use flavored cigars, and in recent years more young people tried a cigar every day than tried a cigarette.
When finalized, this product standard will:
- reduce the appeal of cigars, particularly to youth and young adults, and decrease the likelihood of experimentation, development of nicotine dependence, and progression to regular use; and
- improve public health by increasing the likelihood that existing cigar smokers may quit.
“The proposed rules would help prevent children from becoming the next generation of smokers and help adult smokers quit,” said Health and Human Services Secretary Xavier Becerra. “Additionally, the proposed rules represent an important step to advance health equity by significantly reducing tobacco-related health disparities.”
Today, we’re proposing product standards to prohibit menthol as a characterizing flavor in cigarettes and prohibit all characterizing flavors (other than tobacco) in cigars. https://t.co/Uh5pSdtLnY pic.twitter.com/2GCr6XgAlG— U.S. FDA (@US_FDA) April 28, 2022
As news spread of the FDA’s proposed band on sales of menthol cigarettes and flavored cigars, health organizations across the country weighed in with their support. Health leaders such as the American Lung Association, American Thoracic Society, and the NAACP all lauded the proposed rules.
For decades, the tobacco industry has been targeting African Americans and have contributed to the skyrocketing rates of heart disease, stroke and cancer across our community. The tobacco industry is on a narrow quest for profit, and they have been killing us along the way. The NAACP has been calling for a ban on menthol cigarettes and flavored e-cigarettes for years now, and we applaud the FDA’s latest plan to do just that. It’s about time we prioritize the health and well-being of African Americans.Statement from the NAACP
While the proposal to end the sale of #menthol cigarettes is taking center stage, we also applaud @WhiteHouse and @US_FDA for the proposed rule to end the sale of all flavored #cigars. #Black youth have highest rates of cigar use in U.S.— American Lung Association (@LungAssociation) April 28, 2022
The ATS strongly supports the FDA proposed action to remove menthol-flavored cigarettes and flavored cigars from the U.S. marketplace. Our only regret is that it has taken the FDA so long to initiate this essential ruling to protect America’s youth and minority populations from flavored tobacco products.
The science is clear that the presence of menthol and other flavors in tobacco products increase youth tobacco initiation. Menthol in cigarettes also makes it harder to quit smoking. Internal industry documents show that Big Tobacco has long known that flavored tobacco products lure kids into tobacco addiction. In addition, Big Tobacco intentionally marketed menthol cigarettes to minority communities.
When fully implemented, the FDA’s proposed rules will save lives, improve health equity, and help break the cycle of tobacco addiction.Hasmeena Kathuria, MD, ATS Tobacco Action Committee vice-chair, speaking on behalf of the ATS
More information is available on the FDA website.